• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L. PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS25
Device Problem Activation Failure (3270)
Patient Problem No Information (3190)
Event Date 10/10/2018
Event Type  Injury  
Manufacturer Narrative
The returned prosthesis valve was received in general good conditions.The returned accessories were received blood stained.Given that the surgeon apparently converted to full-sternotomy after the initial implant attempt, it is possible that the surgical approach contributed to the reported event.Additionally, given that a size 21 perimount valve was ultimately implanted, mis-sizing may also have been a contributing factor.
 
Event Description
A perceval valve was implanted on (b)(6) 2018.The physician stated that, during sizing, the large sizer passed through easily, while the medium (pvs25) sizer sat on the annulus.It was reported that the physician had difficulty removing the holder from the valve, but that the valve positioning looked good after it was removed.After weaning from bypass, paravalvular leak was identified.The aorta was then reopened, and folding of the valve was identified.The physician performed a full sternotomy, explanted the perceval valve and implanted a size 21 perimount valve.
 
Manufacturer Narrative
Valve was implanted via full sternotomy, not mini-sternotomy.
 
Event Description
A perceval valve was implanted on (b)(6) 2018 via full sternotomy.It was reported that the physician had difficulty removing the holder from the valve, but that the valve positioning looked good after it was removed.After weaning from bypass, paravalvular leak was identified.The aorta was then reopened, and folding of the valve was identified.The physician performed a full sternotomy, explanted the perceval valve and implanted a size 21 perimount valve.It was reported that the physician could also have implanted a size 23 perimount valve.The patient outcome was good.
 
Event Description
A perceval valve was implanted on (b)(6) 2018 via mini-sternotomy.It was reported that the physician had difficulty removing the holder from the valve, but that the valve positioning looked good after it was removed.After weaning from bypass, paravalvular leak was identified.The aorta was then reopened, and folding of the valve was identified.The physician performed a full sternotomy, explanted the perceval valve and implanted a size 21 perimount valve.The patient outcome was good.
 
Manufacturer Narrative
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Visual inspection of the returned prosthesis did not reveal any elements of non-conformity.A collapsing simulation was performed, and the valve was successfully collapsed without observing any anomalies.A subsequent deployment simulation was performed, and did not reveal any anomalies.No paravalvular leak was identified after the valve was deployed.Based on the performed analyses, the reported event cannot be explained by any factor intrinsic to the involved device.Given that a size 21 perimount valve was ultimately implanted, the event can reasonably be attributed to mis-sizing.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L.
strada crescentino snc
saluggia, vc
MDR Report Key8052063
MDR Text Key127363122
Report Number3005687633-2018-00207
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 12/21/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/08/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/04/2022
Device Model NumberPVS25
Device Catalogue NumberICV1210
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/17/2018
Was the Report Sent to FDA? No
Date Manufacturer Received12/05/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age78 YR
Patient Weight64
-
-